General Information of the Compound
Compound ID
CP0575358
Compound Name
2,3-diphenyl-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine
    Show/Hide
Structure
Formula
C19H19N3
Molecular Weight
289.382
Canonical SMILES
C1Cc2nn(c(c2CCN1)-c1ccccc1)-c1ccccc1
    Show/Hide
InChI
InChI=1S/C19H19N3/c1-3-7-15(8-4-1)19-17-11-13-20-14-12-18(17)21-22(19)16-9-5-2-6-10-16/h1-10,20H,11-14H2
    Show/Hide
InChIKey
MXOUMFAGXNVEAJ-UHFFFAOYSA-N
Physicochemical Property
logP
3.2275
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
29.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 24873257
SID: 50128397
ChEMBL ID
CHEMBL4750414
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 150 nM
   TI
   LI
   LO
   TS